{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:33:16Z","timestamp":1775151196185,"version":"3.50.1"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Pulmonary fibrosis (PF) is a severe disease that can lead to respiratory failure and even death. However, currently there is no effective treatment available for patients with PF. Mesenchymal stem cells (MSCs) have been recently shown to have therapeutic potential for PF. We analyzed the literature focused of MSCs and PF to provide a comprehensive understanding of the relationship between MSCs and PF.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We searched the Web of Science Core Collection database for literature from 2002 through 2021 that involved MSCs and PF. The included studies were then analyzed using CiteSpace and VOSviewers software.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 1,457 studies were included for analysis. Our findings demonstrated the following: 1) an increasing trend of MSC and PF research; 2) among the 54 countries\/regions of author affiliations, the United States was the most frequent, and the University of Michigan (<jats:italic>n<\/jats:italic> = 64, 2.8%) was the top institution; 3) Rojas Mauricio published the most articles and <jats:italic>PLOS ONE<\/jats:italic> had the most related studies; and 4) keywords, such as idiopathic pulmonary fibrosis, mesenchymal stem cells, and systemic sclerosis, were listed more than 100 times, indicating the research trend. Other common keywords, such as inflammation, myofibroblasts, fibroblasts, aging, telomerase or telomere, and extracellular matrix demonstrate research interests in the corresponding mechanisms.1) The number of publications focused on MSCs and PF research increased during the study period; 2) Among the 54 countries\/regions of author affiliations, most articles were published in the United States of America, and the University of Michigan (<jats:italic>n<\/jats:italic> = 64, 2.8%) had the largest number of publications; 3) Rojas Mauricio published the most articles and <jats:italic>PLOS ONE<\/jats:italic> had the most related studies; 4) Keywords, such as idiopathic pulmonary fibrosis, MSCs, and systemic sclerosis, were listed more than 100 times, representing a research trend. Other common keywords included inflammation, myofibroblasts, fibroblasts, aging, telomerase or telomere, and extracellular matrix.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> During the past 2 decades, MSCs have been proposed to play an important role in PF treatment. An increasing amount of literature focused on MSCs and PF research has been published. Our findings provide insight into the current status and research trends in the field of MSCs and PF research during the past 2 decades, which could help researchers understand necessary research directions. In the future, more preclinical and clinical studies should be conducted in this field to support the application of MSCs in the treatment of PF.<\/jats:p>","DOI":"10.3389\/fphar.2023.1136761","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T04:46:06Z","timestamp":1688445966000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Mesenchymal stem cells and pulmonary fibrosis: a bibliometric and visualization analysis of literature published between 2002 and 2021"],"prefix":"10.3389","volume":"14","author":[{"given":"Yanli","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongdi","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/sctm.19-0205","article-title":"Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome","volume":"9","author":"Abraham","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/sctm.19-0037","article-title":"First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline","volume":"9","author":"Averyanov","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1172\/jci68782","article-title":"Type 2 alveolar cells are stem cells in adult lung","volume":"123","author":"Barkauskas","year":"2013","journal-title":"J. Clin. Investig."},{"key":"B4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1164\/rccm.201306-1043OC","article-title":"Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response","volume":"189","author":"Bustos","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.5966\/sctm.2015-0337","article-title":"Hepatocyte growth factor is required for mesenchymal stromal cell protection against bleomycin-induced pulmonary fibrosis","volume":"5","author":"Cahill","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"00773-2020","DOI":"10.1183\/23120541.00773-2020","article-title":"Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial","volume":"7","author":"Campo","year":"2021","journal-title":"ERJ Open Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13287-018-0970-6","article-title":"Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis","volume":"9","author":"C\u00e1rdenes","year":"2018","journal-title":"Stem Cell. Res. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2174\/1574888x15666200422104423","article-title":"Regulation and effect of telomerase and telomeric length in stem cells","volume":"16","author":"Celtikci","year":"2021","journal-title":"Curr. Stem Cell. Res. Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/resp.12343","article-title":"A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Chambers","year":"2014","journal-title":"Respirology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/jdis-2017-0006","article-title":"Science mapping: A systematic review of the literature","volume":"2","author":"Chen","year":"2017","journal-title":"J. Data Inf. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.7150\/thno.33741","article-title":"Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly","volume":"9","author":"Chu","year":"2019","journal-title":"Theranostics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00109-019-01776-y","article-title":"Current understanding of the immunosuppressive properties of mesenchymal stromal cells","volume":"97","author":"de Castro","year":"2019","journal-title":"J. Mol. Med. Berl."},{"key":"B13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3727\/096368915x686841","article-title":"Human umbilical cord mesenchymal stem cells: A new era for stem cell therapy","volume":"24","author":"Ding","year":"2015","journal-title":"Cell. Transpl."},{"key":"B14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-2184.1970.tb00347.x","article-title":"The development of fibroblast colonies in monolayer cultures of Guinea-pig bone marrow and spleen cells","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell. Tissue Kinet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/cphy.c200006","article-title":"Extracellular vesicles as unique signaling messengers: Role in lung diseases","volume":"11","author":"Gao","year":"2020","journal-title":"Compr. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.chest.2016.10.061","article-title":"Allogeneic human mesenchymal stem cells in patients with idiopathic pulmonary fibrosis via intravenous delivery (aether): A phase I safety clinical trial","volume":"151","author":"Glassberg","year":"2017","journal-title":"Chest"},{"key":"B17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/biof.1587","article-title":"The role of Interleukin 1 receptor antagonist in mesenchymal stem cell-based tissue repair and regeneration","volume":"46","author":"Harrell","year":"2020","journal-title":"Biofactors"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4236973","DOI":"10.1155\/2019\/4236973","article-title":"Mesenchymal stem cell-based therapy of inflammatory lung diseases: Current understanding and future perspectives","volume":"2019","author":"Harrell","year":"2019","journal-title":"Stem Cells Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"117290","DOI":"10.1016\/j.lfs.2020.117290","article-title":"Human amniotic mesenchymal stem cells alleviate paraquat-induced pulmonary fibrosis in rats by inhibiting the inflammatory response","volume":"243","author":"He","year":"2020","journal-title":"Life Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41598-020-79664-6","article-title":"Interferon-\u03b3 enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis","volume":"11","author":"Kanai","year":"2021","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pupt.2017.03.016","article-title":"Lung cancer in patients with idiopathic pulmonary fibrosis","volume":"45","author":"Karampitsakos","year":"2017","journal-title":"Pulm. Pharmacol. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3389\/fphar.2020.00842","article-title":"Knowledge mapping of drug-induced liver injury: A scientometric investigation (2010-2019)","volume":"11","author":"Ke","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.5966\/sctm.2016-0054","article-title":"Oncostatin M-preconditioned mesenchymal stem cells alleviate bleomycin-induced pulmonary fibrosis through paracrine effects of the hepatocyte growth factor","volume":"6","author":"Lan","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s13287-021-02496-2","article-title":"Mesenchymal stem cell therapy in pulmonary fibrosis: A meta-analysis of preclinical studies","volume":"12","author":"Li","year":"2021","journal-title":"Stem Cell. Res. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.toxlet.2017.02.016","article-title":"Bone marrow mesenchymal stem cells attenuate silica-induced pulmonary fibrosis via paracrine mechanisms","volume":"270","author":"Li","year":"2017","journal-title":"Toxicol. Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"8861","DOI":"10.1074\/jbc.RA118.006615","article-title":"Telomerase reverse transcriptase ameliorates lung fibrosis by protecting alveolar epithelial cells against senescence","volume":"294","author":"Liu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e128060","DOI":"10.1172\/jci.insight.128060","article-title":"Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes","volume":"4","author":"Mansouri","year":"2019","journal-title":"JCI Insight"},{"key":"B29","doi-asserted-by":"publisher","first-page":"797292","DOI":"10.3389\/fphar.2021.797292","article-title":"Idiopathic pulmonary fibrosis: An update on pathogenesis","volume":"12","author":"Mei","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2147\/jir.S280958","article-title":"Genetic risk factors for idiopathic pulmonary fibrosis: Insights into immunopathogenesis","volume":"13","author":"Michalski","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bone.2019.03.041","article-title":"Aging and lineage allocation changes of bone marrow skeletal (stromal) stem cells","volume":"123","author":"Nehlin","year":"2019","journal-title":"Bone"},{"key":"B32","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1165\/rcmb.2017-0326OC","article-title":"PD-1\/PD-L1 pathway mediates the alleviation of pulmonary fibrosis by human mesenchymal stem cells in humanized mice","volume":"58","author":"Ni","year":"2018","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"Emt: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e202002120","DOI":"10.1083\/jcb.202002120","article-title":"Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging","volume":"219","author":"Pi\u00f1eiro-Hermida","year":"2020","journal-title":"J. Cell. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/s0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/1747493018778713","article-title":"Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke","volume":"13","author":"Sacks","year":"2018","journal-title":"Int. J. Stroke"},{"key":"B38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13287-022-02746-x","article-title":"Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis","volume":"13","author":"Saleh","year":"2022","journal-title":"Stem Cell. Res. Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1513\/pats.200601-003TK","article-title":"Role of epithelial cells in idiopathic pulmonary fibrosis: From innocent targets to serial killers","volume":"3","author":"Selman","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.biopha.2018.10.108","article-title":"Overexpression of CXCR7 promotes mesenchymal stem cells to repair phosgene-induced acute lung injury in rats","volume":"109","author":"Shao","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e143226","DOI":"10.1172\/jci143226","article-title":"Immune dysregulation as a driver of idiopathic pulmonary fibrosis","volume":"131","author":"Shenderov","year":"2021","journal-title":"J. Clin. Investig."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2016.12.005","article-title":"Toll-like receptors as a key regulator of mesenchymal stem cell function: An up-to-date review","volume":"315","author":"Shirjang","year":"2017","journal-title":"Cell. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.nano.2018.06.002","article-title":"Effects of static magnetic fields on natural or magnetized mesenchymal stromal cells: Repercussions for magnetic targeting","volume":"14","author":"Silva","year":"2018","journal-title":"Nanomedicine"},{"key":"B44","first-page":"724","article-title":"CiteSpace II: Visualization and knowledge discovery in bibliographic databases","volume":"2005","author":"Synnestvedt","year":"2005","journal-title":"AMIA Annu. Symp. Proc."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.3390\/curroncol28060382","article-title":"Advances in breast cancer management and extracellular vesicle research, a bibliometric analysis","volume":"28","author":"Teles","year":"2021","journal-title":"Curr. Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1479-5876-11-171","article-title":"A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis","volume":"11","author":"Tzouvelekis","year":"2013","journal-title":"J. Transl. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"8613","DOI":"10.1002\/jcp.29706","article-title":"Mesenchymal stem cell-derived extracellular vesicles suppress the fibroblast proliferation by downregulating FZD6 expression in fibroblasts via micrRNA-29b-3p in idiopathic pulmonary fibrosis","volume":"235","author":"Wan","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1495130","DOI":"10.1155\/2019\/1495130","article-title":"The state of exosomes research: A global visualized analysis","volume":"2019","author":"Wang","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"B49","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cmet.2020.10.004","article-title":"FBW7 mediates senescence and pulmonary fibrosis through telomere uncapping","volume":"32","author":"Wang","year":"2020","journal-title":"Cell. Metab."},{"key":"B50","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1111\/jcmm.16621","article-title":"Mesenchymal stem cells ameliorate silica-induced pulmonary fibrosis by inhibition of inflammation and epithelial-mesenchymal transition","volume":"25","author":"Wei","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1164\/rccm.201705-0925OC","article-title":"Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation","volume":"197","author":"Willis","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.amjms.2019.01.010","article-title":"Epithelial injury and dysfunction in the pathogenesis of idiopathic pulmonaryfibrosis","volume":"357","author":"Winters","year":"2019","journal-title":"Am. J. Med. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"787228","DOI":"10.3389\/fmed.2021.787228","article-title":"Mapping knowledge structure and themes trends of osteoporosis in rheumatoid arthritis: A bibliometric analysis","volume":"8","author":"Wu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13287-017-0535-0","article-title":"Umbilical cord-derived mesenchymal stem cells on scaffolds facilitate collagen degradation via upregulation of MMP-9 in rat uterine scars","volume":"8","author":"Xu","year":"2017","journal-title":"Stem Cell. Res. Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"639657","DOI":"10.3389\/fcell.2021.639657","article-title":"Therapeutic applications of mesenchymal stem cells in idiopathic pulmonary fibrosis","volume":"9","author":"Yang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fphar.2020.00037","article-title":"Lignans: Quantitative analysis of the research literature","volume":"11","author":"Yeung","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2457082","DOI":"10.1155\/2019\/2457082","article-title":"CXCR4-Overexpressing umbilical cord mesenchymal stem cells enhance protection against radiation-induced lung injury","volume":"2019","author":"Zhang","year":"2019","journal-title":"Stem Cells Int."},{"key":"B58","doi-asserted-by":"publisher","first-page":"739810","DOI":"10.3389\/fmed.2021.739810","article-title":"Telomere dysfunction in idiopathic pulmonary fibrosis","volume":"8","author":"Zhang","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1059434","DOI":"10.3389\/fphar.2022.1059434","article-title":"Senescent AEC\u2161 and the implication for idiopathic pulmonary fibrosis treatment","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/foods9020166","article-title":"Knowledge domain and emerging trends in vinegar research: A bibliometric review of the literature from WoSCC","volume":"9","author":"Zhang","year":"2020","journal-title":"Foods"},{"key":"B61","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s13287-021-02551-y","article-title":"Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: A systematic review and implication for clinical application","volume":"12","author":"Zhao","year":"2021","journal-title":"Stem Cell. Res. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1136761\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T04:46:10Z","timestamp":1688445970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1136761\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":61,"alternative-id":["10.3389\/fphar.2023.1136761"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1136761","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,4]]},"article-number":"1136761"}}